Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) was $5.30 for the day, down -7.02% from the previous closing price of $5.70. In other words, the price has decreased by -$7.02 from its previous closing price. On the day, 1.86 million shares were traded. BDTX stock price reached its highest trading level at $5.72 during the session, while it also had its lowest trading level at $5.13.
Ratios:
Our analysis of BDTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.82 and its Current Ratio is at 6.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.19.
On June 30, 2023, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2 to $10.
H.C. Wainwright Upgraded its Neutral to Buy on June 28, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 17 ’23 when BIOTECH GROWTH N V bought 400,000 shares for $2.34 per share. The transaction valued at 934,080 led to the insider holds 8,517,839 shares of the business.
Behbahani Ali bought 1,000,000 shares of BDTX for $5,000,000 on Jul 05 ’23. The Director now owns 4,448,757 shares after completing the transaction at $5.00 per share. On Jul 05 ’23, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 935,850 shares for $5.00 each. As a result, the insider paid 4,679,250 and bolstered with 3,213,828 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 274104352 and an Enterprise Value of 168002592.
Stock Price History:
Over the past 52 weeks, BDTX has reached a high of $6.85, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is 10.64%, while the 200-Day Moving Average is calculated to be 52.86%.
Shares Statistics:
BDTX traded an average of 607.28K shares per day over the past three months and 615290 shares per day over the past ten days. A total of 51.65M shares are outstanding, with a floating share count of 38.11M. Insiders hold about 26.30% of the company’s shares, while institutions hold 68.13% stake in the company. Shares short for BDTX as of 1711584000 were 2044244 with a Short Ratio of 3.37, compared to 1709164800 on 1779444. Therefore, it implies a Short% of Shares Outstanding of 2044244 and a Short% of Float of 6.29.
Earnings Estimates
The current market rating for Black Diamond Therapeutics Inc (BDTX) reflects the collective analysis of USD/BDT analysts closely monitoring its performance.The consensus estimate for the next quarter is $15.00, with high estimates of $233.15 and low estimates of $86.17.
EPS for the following year is $Stocks, with Currency analysts recommending between $Stocks and $Stocks.
